@homemaker After the recent run up, its trading at ~30 times next year earnings. Reference: GMM Pfaudler: A safe way to play the Pharma/Chemical cycle
I started adding gradually from 1050. Considering their market share, quality products, positive changes on management relation and sector tailwind, story looks good for next 2-3 years. There may be positive surprises, while downside looks limited IMO. Daily trading liquidity seems to be low.
How good it turns out to be only time will tell 